A Flavone from Manilkara indica as a Specific Inhibitor against Aldose Reductase in Vitro

Planta Medica

Volumn 69, Issue 9, 2003, Pages 853-855

  Haraguchi, Hiroyuki ^a   Hayashi, Ryosuke ^a   Ishizu, Takashi ^a   Yagi, Akira ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,7,3',4',5' PENTAHYDROXYFLAVONE 6 GLUCOSIDE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; FLAVONE DERIVATIVE; FLAVONOID GLYCOSIDE; GLUCOSIDE; GLYCERALDEHYDE; HYDROXYL GROUP; ISOAFFINETIN; MANIKARA INDICA EXTRACT; PLANT EXTRACT; RECOMBINANT ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; LENS; MANIKARA INDICA; NONHUMAN; PLANT LEAF; RAT; STRUCTURE ACTIVITY RELATION; SWINE;

ALDEHYDE REDUCTASE; ANIMALS; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; INHIBITORY CONCENTRATION 50; MANILKARA; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

MANILKARA; SUIDAE; SUS SCROFA;

EID: 0242288800     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43218     Document Type: Article

References (14)

1. Portte D Jr, Schwartz M W. Diabetes complications: why is glucose potentially toxic? Science 1996; 272: 699-700
2. Kador PF. The role of aldose reductase in the development of diabetic complications. Medicinal Research Review 1988; 8: 325-52
3. Tomlison DR, Stevens EJ, Diemel LT. Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends in Pharmacological Science 1994; 15: 293-7
4. Kador PF, Robison WG, Kinoshita JH. The pharmacology of aldose reductase inhibitors. Annual Review of Pharmacology and Toxicology 1985; 25: 691-714
5. 13NMR spectroscopy of flavonoids. In: Harborne JB. editor. The Flavonoids; Advance in Research. London: Chapman & Hall, 1982: 19-56
6. Costantino L, Rastelli G, Vianello P, Cignarella G, Barlocco D. Diabetes complications and their potential prevention: aldose reductase inhibition and other approach. Medicinal Research Review 1999; 19: 3-23
7. Schade SZ, Early SL, William TR, Kezdy FJ, Heinrikson RL, Grimshaw CE, Doughty CC. Sequence analysis of bovine lens aldose reductase. Journal of Biological Chemistry 1990; 265: 3628-35
8. Haraguchi H, Ohmi I, Sakai S, Fukuda A, Toihara Y, Fujimoto T, Okamura N. Yagi A. Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes. Journal of Natural Products 1996; 59: 443-5
9. Sato S, Kador PF. Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochemical Pharmacology 1990; 40: 1033-42
10. Davis RA, Mayfield CA, Aull JL, DeRuiter J. Enzyme selectivity analyses of arylsulfonylamino acid aldose reductase inhibitors. Journal of Enzyme Inhibition 1993; 7: 87-96
11. Hodnick WF, Duval DL, Pardini RS. Inhibition of mitochondrial respiration and cyanide-stimulated generation of reactive oxygen species by selected flavonoids. Biochemical Pharmacology 1994; 47: 573-80
12. Matsuda H, Morikawa T, Toguchida I, Yoshikawa M. Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chemical and Pharmacological Bulletin 2002; 50: 788-95
13. Haraguchi H, Ohmi I, Masuda H, Tamura Y, Mizutani K. Tanaka O, Chou WH. Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes. Experientia 1996; 52: 564-7
14. Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochimica et Biophysica Acta 1991; 1078: 171-8